| Breast Cancer |
1 |
1 |
| Advanced and Metastatic Breast Cancer |
0 |
0.86 |
| Cancer |
0 |
0.76 |
| Breast |
0 |
0.34 |
| Match |
0 |
0.28 |
| Medical Life |
0 |
0.28 |
| Brain |
0 |
0.21 |
| Endocrine Therapy |
0 |
0.21 |
| Memory |
0 |
0.21 |
| Blood-Brain Barrier |
0 |
0.2 |
| Aromatase Inhibitors |
0 |
0.14 |
| Estrogen |
0 |
0.14 |
| Cognitive Impairment |
0 |
0.1 |
| A-Scan Biometry |
0 |
0.07 |
| Blood |
0 |
0.07 |
| Care and Maintenance of Vision |
0 |
0.07 |
| Cataract |
0 |
0.07 |
| Chemotherapy |
0 |
0.07 |
| Cognition |
0 |
0.07 |
| Cytokines |
0 |
0.07 |
| Epidemiology |
0 |
0.07 |
| Fatigue |
0 |
0.07 |
| Impairment |
0 |
0.07 |
| Mild Cognitive Impairment |
0 |
0.07 |
| Neoadjuvant Therapy |
0 |
0.07 |
| Psychosocial |
0 |
0.07 |
| Receptors |
0 |
0.07 |
| Scan |
0 |
0.07 |